🇺🇸 FDA
Pipeline program

Not the same excipients as Test, Balinatunfib

DRI17822

Phase 2 small_molecule active

Quick answer

Not the same excipients as Test, Balinatunfib for Colitis Ulcerative is a Phase 2 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pharma Bristol-Myers Squibb
Indication
Colitis Ulcerative
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials